What is MaxQ?
MaxQ is at the forefront of developing advanced thermal packaging systems designed to ensure the integrity of temperature-sensitive biological and pharmaceutical products. Their product suite, including MaxPlus coolers and bespoke transport solutions, is engineered to meet the stringent demands of healthcare and logistics providers such as hospitals, blood banks, and specialty pharmacies. By focusing on compliance, efficiency, and sustainability, MaxQ's offerings aim to reduce the risks associated with cold chain logistics, thereby enhancing return-on-investment for their clients and minimizing the challenges of managing temperature-controlled inventory.
How much funding has MaxQ raised?
MaxQ has raised a total of $1.3M across 1 funding round:
Series A
$1.3M
Series A (2017): $1.3M with participation from i2E Inc
Key Investors in MaxQ
i2E Inc
i2E Inc is an engineering firm focused on technical assistance and project monitoring, particularly in the energy and environmental sectors. Their involvement suggests a strategic interest in MaxQ's operational efficiency and potentially its sustainable packaging solutions.
What's next for MaxQ?
With a substantial enterprise-level funding history and a recent strategic investment, MaxQ is poised for significant scaling and innovation. The company's focus on critical cold chain solutions positions it to capitalize on the growing global demand for reliable transportation of pharmaceuticals and biologics. Future developments are likely to involve further enhancements to their product lines, expansion into new geographical markets, and strategic partnerships to solidify their position as a leader in temperature-controlled logistics. The company's commitment to compliance and efficiency suggests a continued emphasis on technological advancement and operational excellence.
See full MaxQ company page
